Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test.
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...